Lupin Pharmaceuticals — Lupin Limited
Lupin Limited is a Public Non-govt company company incorporated in 1983 and based in Maharashtra, India. Lupin Limited operates in Manufacturing (NIC 24100) with authorized capital of ₹200.00 Cr and paid-up capital of ₹90.91 Cr. For 2025-26, the company reported revenue of ₹19512.66 Cr and profit after tax of ₹6366.56 Cr. The board has 3 active directors. RegisterKaro's provisional Compliance Health Score for the company is 100/100 (grade A), based on 4 of 9 signals — full scoring is pending extraction of the company's MCA filing history.
Lupin Pharmaceuticals - Global pharmaceutical company transforming hope into healing with diverse offerings.
Quick facts
Directors
3 activeMCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | +34d | filed |
| MGT-7 | FY2024-25 | 23 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | 0d | filed |
| MGT-7 | FY2023-24 | 21 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | +11d | filed |
| MGT-7 | FY2022-23 | 23 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Lupin Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 689735210 | ICICI Bank Ltd(Bank) | ₹3.76 Cr | 04 Jul 2023 | Open |
| 631107985 | Kotak Mahindra Bank Ltd(Bank) | ₹13.59 Cr | 27 Jan 2020 | Open |
| 545328671 | ICICI Bank Ltd(Bank) | ₹7.73 Cr | 12 Mar 2019 | Open |
| 253051470 | ICICI Bank Ltd(Bank) | ₹5.73 Cr | 27 Jan 2021 | Open |
Charge IDs, lenders & amounts for Lupin Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
MCA| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| 2025-26 | — | ||||
| 2023-24 | — | ||||
| 2022-23 | — | ||||
| 2021-22 | — |
Detailed Financials
4 FYs| Line item | 2025-26 | 2023-24 | 2022-23 | 2021-22 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue from operations | ||||
| Other income | ||||
| Total income | ||||
| Total expenses | ||||
| Profit before tax | ||||
| Profit / (Loss) after tax | ||||
| Balance sheet | ||||
| Equity / Net worth | ||||
| Borrowings | ||||
| Current liabilities | ||||
| Total liabilities | ||||
| Current assets | ||||
| Cash & equivalents | ||||
| Total assets | ||||
| Employees | — | — | — | — |
Cash-flow statement renders when the AOC-4 XBRL Cash Flow context is parsed during the extract phase.
Compounded Annual Growth Rate
| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue2025-26 | +21.0% | +99.0% | — | |
| Profit after Tax2025-26 | +770.0% | — | — | |
| Net Worth2023-24 | +33.0% | — | — |
Financial Ratios
| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| 2021-22 | -1.61% | — | -1.04% | -0.85% | — | |||
| 2022-23 | +3.77% | -4.36% | +2.31% | +1.87% | — | |||
| 2023-24 | +15.86% | +30.26% | +11.29% | +9.33% | — | |||
| 2025-26 | +32.63% | +33.05% | — | — | — |
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 4 | 2,42,96,185 | 89.99% |
| Institutional Investors | 3 | 11,64,816 | 4.31% |
| Public & Others | 53 | 15,37,679 | 5.70% |
Promoter, institutional & public holding for Lupin Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
14 peersEvents & timeline
4External data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.